June 30, 2025 Hospital Services – Coverage of Gene Therapies for Sickle Cell Disease LAC 50:V.120

- Hospital Services – Coverage of Gene Therapies for Sickle Cell Disease LAC 50:V.120

Amends the provisions governing inpatient hospital services, to allow reimbursement for gene therapies for sickle cell disease outside the per diem rate and paid based on the actual acquisition cost in order to take advantage of a federal rebate.

Contact Information: Kimberly Sullivan, JD, Bureau of Health Services Financing, P.O. Box 91030, Baton Rouge, LA 70821-9030

RELATED ITEMS

Surgeon General Ralph L. Abraham, M.D.

Secretary Bruce D. Greenstein

Powered by Cicero Government